Lista de obras - Vasilis Karavasilis - Dominio Público Uruguay

90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?

artículo científico publicado en 2008

AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Canc

scientific article published on 15 June 2018

Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.

artículo científico

Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literature.

artículo científico publicado en 2014

Advances in the treatment of soft tissue sarcoma: focus on eribulin.

artículo científico publicado en 2018

Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1

artículo científico publicado en 2005

Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.

scientific article published on 28 December 2016

Chest drainage systems in use.

artículo científico

Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.

artículo científico publicado en 2010

Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma

scientific article published on 01 January 2006

Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.

artículo científico

Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?

artículo científico publicado en 2015

Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer.

artículo científico publicado en 2015

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

artículo científico publicado en 2015

Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.

artículo científico publicado en 2018

Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy.

artículo científico publicado en 2010

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.

artículo científico publicado en 2016

Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.

artículo científico publicado en 2015

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients

artículo científico publicado en 2016

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).

artículo científico publicado en 2012

Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction

artículo científico publicado en 2006

Heimlich valve and pneumothorax

artículo científico publicado en 2015

Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital

artículo científico publicado en 2008

Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression

artículo científico publicado en 2002

Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel.

artículo científico publicado en 2004

Invasive thymoma: a clinical study of 23 cases

scientific article published on 01 January 2001

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

artículo científico publicado en 2017

Leiomyosarcoma as a second metachronous malignant neoplasm following colon adenocarcinoma. A case report and review of the literature.

artículo científico publicado en 2001

Matrix metalloproteinases in carcinoma of unknown primary

scientific article published on 01 November 2005

Metastatic breast carcinoma confined to bone: portrait of a clinical entity

artículo científico publicado en 2004

Minimally invasive procedures

artículo científico publicado en 2015

Novel therapeutic approaches in chondrosarcoma.

artículo científico publicado en 2017

Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.

artículo científico publicado en 2005

Pacemaker insertion

artículo científico publicado en 2015

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping

artículo científico publicado en 2018

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC).

artículo científico publicado en 2009

Pneumothorax from diagnosis to treatment, hands on course: Part II.

artículo científico publicado en 2015

Pneumothorax: an up to date "introduction".

artículo científico publicado en 2015

Prognostic factors for long term survival in patients with advanced non-small cell lung cancer

artículo científico publicado en 2016

Pseudomonas fluorescens infections in clinical practice.

artículo científico publicado en 2006

Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer

artículo científico publicado en 2014

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage

artículo científico publicado en 2015

Revisiting bleomycin from pathophysiology to safe clinical use.

artículo científico

Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.

artículo científico publicado en 2015

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

artículo científico publicado en 2008

Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy

artículo científico publicado en 2009

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

artículo científico publicado en 2015

Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).

artículo científico publicado en 2015

Use of proteins as biomarkers and their role in carcinogenesis.

artículo científico publicado en 2015

Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration

artículo científico publicado en 1999

Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone.

artículo científico publicado en 2015

Lista de obras de Vasilis Karavasilis

90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?

AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Canc

Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.

Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literature.

Advances in the treatment of soft tissue sarcoma: focus on eribulin.

Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1

Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.

Chest drainage systems in use.

Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.

Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma

Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.

Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?

Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer.

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.

Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy.

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.

Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).

Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction

Heimlich valve and pneumothorax

Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital

Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression

Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel.

Invasive thymoma: a clinical study of 23 cases

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

Leiomyosarcoma as a second metachronous malignant neoplasm following colon adenocarcinoma. A case report and review of the literature.

Matrix metalloproteinases in carcinoma of unknown primary

Metastatic breast carcinoma confined to bone: portrait of a clinical entity

Minimally invasive procedures

Novel therapeutic approaches in chondrosarcoma.

Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.

Pacemaker insertion

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC).

Pneumothorax from diagnosis to treatment, hands on course: Part II.

Pneumothorax: an up to date "introduction".

Prognostic factors for long term survival in patients with advanced non-small cell lung cancer

Pseudomonas fluorescens infections in clinical practice.

Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage

Revisiting bleomycin from pathophysiology to safe clinical use.

Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).

Use of proteins as biomarkers and their role in carcinogenesis.

Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration

Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone.